Canada markets open in 3 hours 24 minutes

International Biotechnology Trust plc (IBT.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
609.13-6.87 (-1.11%)
As of 10:32AM BST. Market open.
Currency in GBp

Valuation Measures4

Market Cap (intraday) 232.37M
Enterprise Value N/A
Trailing P/E 36.69
Forward P/E 714.29
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)29.43
Price/Book (mrq)0.86
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.21
52-Week Change 3-6.38%
S&P500 52-Week Change 323.10%
52 Week High 3742.61
52 Week Low 3548.00
50-Day Moving Average 3651.85
200-Day Moving Average 3629.43

Share Statistics

Avg Vol (3 month) 360.14k
Avg Vol (10 day) 352.51k
Shares Outstanding 537.72M
Implied Shares Outstanding 639.1M
Float 8N/A
% Held by Insiders 14.20%
% Held by Institutions 150.61%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.28
Forward Annual Dividend Yield 44.51%
Trailing Annual Dividend Rate 30.28
Trailing Annual Dividend Yield 30.05%
5 Year Average Dividend Yield 44.18
Payout Ratio 4167.96%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 21, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Aug 31, 2023
Most Recent Quarter (mrq)Aug 31, 2023

Profitability

Profit Margin 65.08%
Operating Margin (ttm)126.01%

Management Effectiveness

Return on Assets (ttm)1.30%
Return on Equity (ttm)2.45%

Income Statement

Revenue (ttm)10.47M
Revenue Per Share (ttm)0.26
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)6.81M
Diluted EPS (ttm)0.17
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)32.47M
Total Debt/Equity (mrq)12.01%
Current Ratio (mrq)0.09
Book Value Per Share (mrq)6.88

Cash Flow Statement

Operating Cash Flow (ttm)27.3M
Levered Free Cash Flow (ttm)13.89M